lypressin has been researched along with Diabetes Insipidus, Neurogenic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CHIRMAN, SB; KINSELL, LW | 1 |
| DINGMAN, JF; HAUGER-KLEVENE, JH | 1 |
| EISENBERG, E | 1 |
| Aijaz, N; Blanco, EJ; Blumberg, D; Lane, AH; Wilson, TA | 1 |
4 other study(ies) available for lypressin and Diabetes Insipidus, Neurogenic
| Article | Year |
|---|---|
DIABETES INSIPIDUS. TREATMENT WITH 8-LYSINE VASOPRESSIN IN A NASAL SPRAY.
Topics: Aerosols; Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Drug Therapy; Humans; Lypressin; Lysine; Nasal Sprays; Pharmaceutical Solutions; Pituitary Hormones, Posterior; Respiratory Therapy; Vasopressins | 1964 |
TREATMENT OF DIABETES INSIPIDUS: SYNTHETIC LYSINE VASOPRESSIN NASAL SOLUTION.
Topics: Aerosols; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Diabetes Mellitus; Female; Humans; Hypersensitivity; Lypressin; Lysine; Pregnancy; Pregnancy in Diabetics; Toxicology; Vasopressins; Water Intoxication | 1964 |
DIABETES INSIPIDUS. DIFFICULTIES IN DIAGNOSIS AND TREATMENT; USE OF SYNTHETIC LYSINE-8 VASOPRESSIN IN PATIENTS INTOLERANT OF OTHER THERAPY.
Topics: Aerosols; Arginine Vasopressin; Biological Transport; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Lypressin; Lysine; Patient Discharge; Vasopressins; Water Deprivation | 1965 |
Use of subcutaneous DDAVP in infants with central diabetes insipidus.
Topics: Administration, Intranasal; Antidiuretic Agents; Child, Preschool; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Female; Follow-Up Studies; Humans; Infant; Injections, Subcutaneous; Lypressin; Male; Retrospective Studies | 2006 |